2009
Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus Conference
Kalb R, Strober B, Weinstein G, Lebwohl M. Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus Conference. Journal Of The American Academy Of Dermatology 2009, 60: 824-837. PMID: 19389524, DOI: 10.1016/j.jaad.2008.11.906.Peer-Reviewed Original ResearchConceptsTreatment of psoriasisUse of methotrexateLiver biopsyNational Psoriasis Foundation Medical BoardAppropriate patient selectionNational Psoriasis FoundationEvidence-based studiesMedical boardsMethotrexate therapyPatient selectionRheumatoid arthritisTreatment optionsHepatic fibrosisRisk factorsConsensus conferencePsoriasisSide effectsEffective drugsLast guidelinesMethotrexateValuable optionTreatmentBiopsyTask ForceReport
2007
From the Medical Board of the National Psoriasis Foundation: Monitoring and vaccinations in patients treated with biologics for psoriasis
Lebwohl M, Bagel J, Gelfand J, Gladman D, Gordon K, Hsu S, Kalb R, Kimball A, Korman N, Krueger G, Mease P, Morison W, Paller A, Pariser D, Ritchlin C, Strober B, Van Voorhees A, Weinstein G, Young M, Horn L. From the Medical Board of the National Psoriasis Foundation: Monitoring and vaccinations in patients treated with biologics for psoriasis. Journal Of The American Academy Of Dermatology 2007, 58: 94-105. PMID: 17980456, DOI: 10.1016/j.jaad.2007.08.030.Peer-Reviewed Original ResearchConceptsLiver function testsBiologic therapyNational Psoriasis FoundationCD4 countAntinuclear antibodiesFunction testsPlatelet countPhysical examinationVaccination practicesTumor necrosis factor blockersNecrosis factor blockersTuberculin skin testTreatment of psoriasisBlood cell countEvidence-based studiesMedical boardsFactor blockersPsoriatic arthritisSkin testBlood countConsensus conferenceParticular therapyBlood chemistryPatientsLive vaccine